Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, PR China.
Oral Oncol. 2012 May;48(5):445-9. doi: 10.1016/j.oraloncology.2011.12.002. Epub 2011 Dec 29.
Surgery is the main treatment modality for adenoid cystic carcinoma (ACC) originated from the head and neck. However, the extensive local infiltrative and perineural spread related to this malignancy often cause difficulty to achieve high tumor control. The aim of this study is to evaluate the efficacy of postoperative radiotherapy (RT) in ACC, and to identify prognostic variables associated with treatment outcomes. A retrospective review of 101 patients diagnosed with ACC in the head and neck region was performed. T stage distribution was T1, 25; T2, 35; T3, 18; and T4, 23 patients. All patients were grouped into two arms: surgery alone or combined with postoperative radiotherapy. The 5-year local-regional control (LRC), overall survival (OS) and disease-free survival (DFS) rates for all the patients were 70.5%, 91.7% and 63.2%, respectively. On univariant analysis, postoperative radiotherapy did improve the 5-year LRC and DFS compared to surgery alone (81.0% vs. 53.4%, p=0.0003 and 71.3% vs. 50.0%, p=0.0052, respectively). And patients with T1-T2 lesions achieved better treatment outcomes, whereas stage T3-T4 was associated with high local failure and poor disease-free survival. Furthermore, multivariate analysis revealed that the addition of radiotherapy and early lesions were both favorite predictors for local control and survival rates. The prognosis for ACC of the head and neck was excellent. Surgery combined with postoperative radiotherapy significantly reduced the local failure, and further improved disease-free survival. Nevertheless, the relatively high distant metastasis was an obstacle of curing the ACC patients.
手术是头颈部腺样囊性癌(ACC)的主要治疗方式。然而,由于这种恶性肿瘤广泛的局部浸润和神经周围扩散,常常难以实现高肿瘤控制率。本研究旨在评估术后放疗(RT)在 ACC 中的疗效,并确定与治疗结果相关的预后因素。
对 101 例诊断为头颈部 ACC 的患者进行回顾性研究。T 分期分布为 T1 期 25 例,T2 期 35 例,T3 期 18 例,T4 期 23 例。所有患者分为两组:单纯手术组或手术联合术后放疗组。所有患者的 5 年局部区域控制率(LRC)、总生存率(OS)和无病生存率(DFS)分别为 70.5%、91.7%和 63.2%。
单因素分析显示,与单纯手术相比,术后放疗可提高 5 年 LRC 和 DFS(81.0%比 53.4%,p=0.0003;71.3%比 50.0%,p=0.0052)。T1-T2 病变患者的治疗效果较好,而 T3-T4 期病变与局部失败和无病生存不良相关。此外,多因素分析显示,放疗的加入和早期病变都是局部控制和生存率的有利预测因素。
头颈部 ACC 的预后良好。手术联合术后放疗可显著降低局部失败率,进一步提高无病生存率。然而,相对较高的远处转移是治愈 ACC 患者的障碍。